Loading...
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?
Angiotensin-converting enzyme 2 (ACE2) is the leading player of the protective renin–angiotensin system (RAS) pathway but also the entry receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). RAS inhibitors seemed to interfere with the ACE2 receptor, and their safety was addresse...
Saved in:
| Published in: | Clin Sci (Lond) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Portland Press Ltd.
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8062870/ https://ncbi.nlm.nih.gov/pubmed/33881142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/CS20210182 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|